Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on acute otitis media.

Sharon E. Balter1, Scott F. Dowell

  • 1aEpidemiology and Surveillance Division, National Immunization Program, and bRespiratory Diseases Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Current Opinion in Infectious Diseases
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Use of gloves: current evidence vs. current use.

Current opinion in infectious diseases·2026
Same journal

Understanding challenges to prevention of healthcare related infections.

Current opinion in infectious diseases·2026
Same journal

Harnessing next-generation microbial diagnostics to optimize infection management in immunocompromised hosts.

Current opinion in infectious diseases·2026
Same journal

Epidemiology, treatment and outcomes of antimicrobial-resistant infections in hematopoietic stem cell transplant recipients.

Current opinion in infectious diseases·2026
Same journal

Dengue and chikungunya vaccines past, present and future: implications for travelers.

Current opinion in infectious diseases·2026
Same journal

Oropouche virus: viral evolution, epidemiological trends, and challenges for control.

Current opinion in infectious diseases·2026
See all related articles

Antibiotic resistance is a growing concern, especially for Streptococcus pneumoniae. New vaccines and careful antibiotic use may reduce acute otitis media incidence and prescriptions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing antibiotic resistance in Streptococcus pneumoniae raises significant public health concerns.
  • Otitis media represents the primary reason for antibiotic prescriptions in children within the United States.
  • While antibiotics offer benefits for acute otitis media, shorter courses may suffice for select pediatric patients.

Purpose of the Study:

  • To review the current landscape of antibiotic use for acute otitis media.
  • To discuss the impact of emerging vaccines on otitis media management.
  • To explore strategies for reducing antibiotic prescriptions and mitigating antimicrobial resistance.

Main Methods:

  • Literature review of studies on Streptococcus pneumoniae resistance and otitis media treatment.

Related Experiment Videos

  • Analysis of antibiotic efficacy and resistance patterns.
  • Evaluation of the potential impact of novel vaccines and diagnostic criteria.

    • Main Results:

    • Amoxicillin remains the primary antibiotic choice for acute otitis media, even with high resistance levels.
    • Evidence supports the efficacy of antibiotics for acute otitis media, with potential for shorter treatment durations.
    • Upcoming vaccines (pneumococcal conjugate and live attenuated influenza) are expected to influence otitis media incidence.

    Conclusions:

    • Future reductions in acute otitis media incidence and antibiotic prescriptions are anticipated.
    • Vaccination, refined diagnostic standards, and judicious antibiotic stewardship are key to combating antimicrobial resistance.
    • A multi-faceted approach is necessary to address the challenges posed by drug-resistant Streptococcus pneumoniae and otitis media.